Opiant Pharmacls (OPNT)

HEALTH CARE: PHARMACEUTICALS
SIC: METAL MINING

201 SANTA MONICA BOULEVARD SANTA MONICA, CA 90401

Opiant Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The Company develops pharmacological treatments for substance use, addictive, and eating disorders. Opiant Pharmaceuticals serves patients in the United States.

Data based on most recent fiscal year report
Market Cap39.682 Million Shares Outstanding2.07 Million Avg Volume63.126 Thousand
1-Yr BETA vs S&P TR0.821 Current Ratio2.59 Quick Ratio2.59

Are you looking for this stock instead?

View SEC Filings from OPNT instead.
Q2 2019 All Institutions Hedge Funds 1
To trade OPNT now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 15 3 (0.31%)
Aggregate 13F shares on 06/30/2019: 769.427 Thousand 547.233 Thousand
Aggregate 13F shares on 03/31/2019: 786.436 Thousand 594.141 Thousand
Percent change: -2.16% -7.90%
Funds creating new positions: 1
Funds Adding to an existing position: 5 2
Funds closing out their position: 8 5
Funds reducing their position: 2 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding OPNT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

2 Thousand total shares from 2 transactions

Open Market Sells (S)

20 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

50 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

O'TOOLE DAVID D CHIEF FINANCIAL OFFICER

  • Officer
8,015 2019-08-15 3

POLLACK KEVIN

  • Director
260,814 2019-08-14 0

SKOLNICK PHIL CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-08-01 12

ELLISON MARK JASON HEATH

  • UK MANAGING DIRECTOR
5,530 2019-07-29 2

SILVER GABRIELLE ALISON

  • Director
0 2019-06-12 1

MACDOUGALL ANN L.

  • Director
0 2019-06-12 1

THOMAS THOMAS T.

  • Director
0 2019-06-12 1

DALY RICHARD J

  • Director
0 2019-06-12 1

COLLARD CRAIG A

  • Director
0 2019-06-12 3

CRYSTAL ROGER CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
8,475 2019-04-05 6

WOLF GEOFFREY

  • 10% Owner
No longer subject to file 2018-04-08 0

SINCLAIR MICHAEL EXECUTIVE CHAIRMAN

  • Officer
  • Director
  • 10% Owner
160,170 2017-01-17 0

BELMONT PARTNERS, LLC

MEUSE JOSEPH J

  • Director
  • 10% Owner
132,861,008 2010-04-28 0

KI SEIJIN

  • Director
5,000,000 2009-07-31 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

O'TOOLE DAVID D - Officer CHIEF FINANCIAL OFFICER

2019-08-15 P 1,000 $15.20 a 8,015 8,015.00 direct

O'TOOLE DAVID D - Officer CHIEF FINANCIAL OFFICER

2019-08-13 P 1,000 $15.46 a 7,015 7,015.00 direct

SKOLNICK PHIL - Officer CHIEF SCIENTIFIC OFFICER

2019-08-02 S 1,558 $11.30 d 0 0.00 direct yes

SKOLNICK PHIL - Officer CHIEF SCIENTIFIC OFFICER

2019-08-01 S 8,442 $11.66 d 1,558 0.00 direct yes

SKOLNICK PHIL - Officer CHIEF SCIENTIFIC OFFICER

2019-08-01 M 10,000 d 90,000 0.00 direct yes

SKOLNICK PHIL - Officer CHIEF SCIENTIFIC OFFICER

2019-08-01 M 10,000 $9.00 a 10,000 0.00 direct yes

ELLISON MARK JASON HEATH UK MANAGING DIRECTOR see footnote (1)

2019-07-29 F 24,470 $12.26 d 5,530 5,530.00 indirect

ELLISON MARK JASON HEATH UK MANAGING DIRECTOR see footnote (1)

2019-07-29 M 30,000 $10.00 a 30,000 5,530.00 indirect

ELLISON MARK JASON HEATH UK MANAGING DIRECTOR see footnote (2)

2019-07-29 M 30,000 d 0 5,530.00 indirect

SKOLNICK PHIL - Officer CHIEF SCIENTIFIC OFFICER

2019-07-02 S 2,195 $13.16 d 0 0.00 direct yes

SKOLNICK PHIL - Officer CHIEF SCIENTIFIC OFFICER

2019-07-01 M 10,000 $9.00 a 10,000 0.00 direct yes

SKOLNICK PHIL - Officer CHIEF SCIENTIFIC OFFICER

2019-07-01 S 7,805 $13.20 d 2,195 0.00 direct yes

SKOLNICK PHIL - Officer CHIEF SCIENTIFIC OFFICER

2019-07-01 M 10,000 d 100,000 0.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments